ClinicalTrials.Veeva

Menu
K

Klein & Associates, M.D., P.A. | Cumberland, MD

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Filgotinib
SEL-212
Upadacitinib
ABT-494
Adalimumab
Tanezumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) (SELECT - PsA 1)

This study includes two periods. The main objective of Period 1 is to compare the efficacy of upadacitinib 15 mg once daily (QD) and 30 mg QD versus...

Active, not recruiting
Psoriatic Arthritis
Drug: Placebo to Upadacitinib
Drug: Adalimumab

The primary objective of this study is to evaluate the long-term safety and tolerability of filgotinib in participants who have completed one of the...

Active, not recruiting
Rheumatoid Arthritis
Drug: Filgotinib
Drug: Placebo to match filgotinib

Trial sponsors

Pfizer logo
AbbVie logo
G
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems